Stellar Performance Across Small and Micro Caps

The one-year period ending in early September 2026 has seen a handful of select stocks generate returns that dwarf typical market gains. Cupid, a small cap FMCG company, emerged as the standout performer with an astonishing return of 699.72%. This level of appreciation is exceptional, especially when compared to broader market indices such as the Sensex or Nifty, which typically deliver annual returns in the range of 10-15% under normal conditions.

Close behind, Stellant Securities, a micro cap player in the Non-Banking Financial Company (NBFC) sector, posted a return of 673.16%. MTAR Technologie, operating in the Aerospace & Defense sector as a small cap, also impressed with a 433.3% gain. Bliss GVS Pharma, a small cap pharmaceutical and biotechnology firm, delivered a 342.95% return, while Bhagyanagar Industries, a micro cap in the Non-Ferrous Metals sector, rounded out the top five with a 300.84% increase.

Fundamental and Technical Strengths Driving Gains

These returns are underpinned by strong fundamental and technical factors. Cupid, with a MarketsMOJO score of 75.0 and a Buy rating, boasts an outstanding financial grade, signalling solid earnings growth and balance sheet strength. Its technical grade is bullish, reflecting positive price momentum, although its valuation grade is very expensive, indicating that the stock is trading at a premium relative to earnings and book value. The quality grade is average, suggesting room for improvement in operational metrics or corporate governance.

Similarly, Stellant Securities holds a score of 70.0 with a Buy rating. Its financial grade is very positive, supported by healthy profitability and asset quality, while the technical grade is bullish. The valuation grade is also very expensive, a common theme among these high-flying stocks, reflecting investor enthusiasm and expectations for continued growth. The quality grade remains average, highlighting the need for investors to monitor operational risks.

MTAR Technologie’s mildly bullish technical grade and very positive financial grade, combined with a good quality grade, suggest a well-rounded company with strong growth prospects. However, its valuation is also very expensive, indicating that the market has priced in significant future growth. Bliss GVS Pharma and Bhagyanagar Industries share similar profiles, with strong financials and bullish or mildly bullish technical grades, but differing valuation assessments—Bliss GVS Pharma is very expensive, while Bhagyanagar Industries is fairly valued.

Market Capitalisation and Sectoral Insights

All five top performers fall within the small and micro cap categories, highlighting the potential for outsized gains in these less liquid and often under-researched segments of the market. Cupid and MTAR Technologie are classified as small caps, while Stellant Securities and Bhagyanagar Industries are micro caps. Bliss GVS Pharma also belongs to the small cap universe.

The sectors represented are diverse, spanning FMCG, NBFC, Aerospace & Defense, Pharmaceuticals & Biotechnology, and Non-Ferrous Metals. This diversity underscores that exceptional returns are not confined to a single industry but can be found across various segments, provided the companies exhibit strong fundamentals and positive market sentiment.

Valuation Considerations and Risk Factors

While the returns are impressive, investors should be mindful of the valuation grades assigned to these stocks. Most are rated as very expensive, reflecting high price-to-earnings and price-to-book multiples. This premium pricing suggests that the market has high expectations for future growth, which may not always materialise. Consequently, these stocks carry elevated risk, particularly if earnings disappoint or broader market conditions deteriorate.

Quality grades are generally average, indicating that while financial performance is strong, there may be concerns related to corporate governance, operational efficiency, or earnings consistency. Investors should conduct thorough due diligence and consider these factors when building portfolios with such high-growth stocks.

Comparative Benchmark Performance

To put these returns into perspective, the Sensex and Nifty indices have typically delivered annual returns in the low double digits over the past year. The top five stocks’ returns, ranging from approximately 300% to nearly 700%, represent a multiple of the benchmark performance. This outperformance highlights the potential rewards of investing in smaller companies with strong growth trajectories, albeit with commensurate risks.

Outlook and Investor Takeaways

Looking ahead, these stocks remain on the radar of investors seeking high returns in the small and micro cap space. The bullish technical grades and positive financial assessments suggest continued momentum, although valuation premiums warrant caution. Investors should balance their portfolios with a mix of growth and value stocks and remain vigilant to market developments.

MarketsMOJO’s comprehensive grading system provides valuable insights into the technical, financial, quality, and valuation aspects of these companies, aiding investors in making informed decisions. The Buy ratings across the board reinforce confidence in the growth prospects of these stocks, but ongoing monitoring is essential to manage risk effectively.

Summary

In summary, the past year has been exceptionally rewarding for investors in Cupid, Stellant Securities, MTAR Technologie, Bliss GVS Pharma, and Bhagyanagar Industries. Their returns have far exceeded benchmark indices, driven by strong fundamentals, positive technical trends, and sectoral tailwinds. While valuations are stretched, the overall outlook remains positive, making these stocks noteworthy candidates for growth-oriented portfolios.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →